Merck’s superovulation induction drug Pergoveris gets expanded coverage
01 Apr 2024 //
KOREA BIOMED
Organon`s Biologic Follistim AQ (follitropin) Receives Approval in the U.S.
07 Feb 2024 //
FDA
EMD Serono`s Biologic GONAL-F (follitropin) Receives Approval in the U.S.
13 Nov 2023 //
FDA
Ferring Announces Abstract of the Study of Rekovelle
13 Mar 2023 //
BUSINESSWIRE
Ferring Presents New Data at ESHRE 2021 Supporting the Use of Rekovelle
29 Jun 2021 //
BUSINESSWIRE
FDA Compiles List of NDAs Transitioning to BLAs Next March
24 Sep 2019 //
RAPS